Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is to assess the pharmacodynamics, pharmacokinetics, safety and tolerability of
multiple ascending doses of AZD0328 in patients with schizophrenia